These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6190766)

  • 1. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S
    Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of SV40-TSTA activity with liposomes containing VSV glycolipids.
    Huet C; Ansel S
    Int J Cancer; 1977 Jul; 20(1):61-6. PubMed ID: 71275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells.
    Ansel S; Blangy D
    Int J Cancer; 1984 Oct; 34(4):555-9. PubMed ID: 6092285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific glycolipid antigen(s) in SV40-transformed cell membranes.
    Ansel S; Huet C
    Int J Cancer; 1980 Jun; 25(6):797-803. PubMed ID: 14768710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune control of SV40-induced tumors in mice.
    Pan S; Abramczuk J; Knowles BB
    Int J Cancer; 1987 Jun; 39(6):722-8. PubMed ID: 3034805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
    Coggin JH; Gillis LD; Payne WJ
    J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of simian virus 40 transplantation immunity in hamsters by gel-purified SV40 large T antigen.
    Haddada H; Le Goffic N; Chandrasekaran K; de Vaux Saint Cyr C
    Immunol Lett; 1988 Jul; 18(3):225-9. PubMed ID: 2844659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the surface proteins of SV40-transformed mouse and human cells: absence of SV40-specific proteins.
    Rose TM; Weil R
    Int J Cancer; 1983 May; 31(5):639-48. PubMed ID: 6303969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.
    Gooding LR; O'Connell KA
    J Immunol; 1983 Nov; 131(5):2580-6. PubMed ID: 6313808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of tumorigenic phenotypes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions.
    Lewis AM; Cook JL
    Cancer Res; 1982 Mar; 42(3):939-44. PubMed ID: 6277479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
    Glaser M
    J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced cellular immunity to simian virus 40 tumor-specific surface antigen(s) in adult LVG:LAK hamsters.
    Weppner WA; Coggin JH
    J Natl Cancer Inst; 1980 Apr; 64(4):757-63. PubMed ID: 6245298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen.
    Soule HR; Lanford RE; Butel JS
    J Virol; 1980 Feb; 33(2):887-901. PubMed ID: 6157837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.